CLINICAL_TRIALS
research
· 2017-09-05
Clinical Trial Update: Humoral Determinants of Immunity to Pneumococcal Infection [Phase 4]
Summary
Phase 4 clinical trial update studying humoral determinants of immunity to pneumococcal infection, completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: VA Office of Research and Development | Conditions: Pneumonia, Pneumococcal Infections | Phase 4 | Status: COMPLETED